Extendicare Inc (EXE.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Extendicare Inc (EXE.TO)

32.85

-0.29 (0.88%)

as of Jun 8, 2026, 8:00:00 pm Market Open.

172 watching

Investor Insights

Jun 7, 2026, 12:00 am

This summary was created by AI, based on 4 opinions in the last 12 months.

Extendicare Inc (EXE-T) is attracting attention for its positioning within the growing healthcare sector, particularly as it prepares to cater to an aging population in Ontario. Experts appreciate its strong chart performance and effective margin management, suggesting the company is ready to benefit from increased government funding for home healthcare providers. However, caution is advised due to the market's current exuberance and the presence of well-capitalized private equity competitors. Some analysts express concerns about the stock's current valuation, believing that much of the potential growth may already be reflected in its price. Overall, while the demographic tailwinds are favorable, there is a discernible hesitation regarding its growth prospects relative to peer companies.

Consensus

Cautious

Valuation

Fair Value

Similar

CSH.UN

SELL

Now gov’t regulations in US on their facilities. Market believes this will hammer their margins. He thinks this will be the trend and will affect Canada too. Doesn’t now if the dividend is safe. They have to operate in the environment and we will see if it is safe

HOLD

Will have to face reduced sales. Regulatory problem. Would sell if it pops a dollar or two.

HOLD

75% US and each state sets their own rules. The rules changed suddenly. Knocked the stock very, very hard. Now are saying business is very good and they can make the dividend they are paying. But they aren’t sure what politicians are going to do. Isn’t selling but don’t dive back in.

DON'T BUY

US regulatory body dropped retirement home funding by 12%, which hurt the stock. It will be hard for them to go up in value. Prefers Leisure World (LW-T), where provincial regulations are much simpler to understand.

SELL

Have huge legislative and political risks. Center for Medicaid services announced they were going to cut reimbursement rates for some procedures by 11% going forward. 3rd or 4th time this stock has been down 10%-20% in the last 2 years. (See Top Picks.)

DON'T BUY

Have nursing homes in the US as well as Canada, which are being reimbursed by Medicare and Medicaid. Had a sharp decline today because those reimbursements are going to decline sharply. Doesn't like their exposure to government entities. Dividend could be at risk.

DON'T BUY

His big concern with retirement/nursing homes is the extent the government would feel compelled to become involved. Soon as they get involved, costs go up and profits go down. This REIT would not be on his list.

SELL

Focus in the nursing center, in the US. A lot of litigation in this space, would rather stay in Canada.

COMMENT

Long-term seniors’ care facilities in US and Canada. Complicated business because of government rules/regulations that vary among jurisdictions. They need to keep their beds filled and the rules can be varied so he doesn’t own.

DON'T BUY

Extendicare is the nursing homes in U.S. and Canada. There has been a recent fall in the U.S.side because revenue from the government has decreased, it is a recovery story, volatile. He likes Leisure World better which is an all Ontario nursing home.

HOLD

Nursing homes in US and Canada. Just acquired a company that gave them 16,000 beds. Outperformed last couple of quarters and has restructured its balance sheet so is in a good spot. De-leveraging and getting cheaper funding. Blew away numbers this quarter. Has a little more to go but getting close to being fully priced. Prefers Leisureworld (LW-T).

STRONG BUY

Technically looks great. It is going higher in a difficult market. This is the kind of stock you want to own and to buy more. The right place at the right time.

BUY

Big portion of business in the US. Recent numbers were better than previous. They are doing their job. They are good at it. Likes it despite the complications.

BUY

Big part of its earnings is from the US and the US is always changing the rules. Good yield and has done well. Good yield. Very volatile.

DON'T BUY

An operating business, so he doesn’t like it. Very disappointing Q3. A write down around self-insured liabilities. 3’rd time this year when an unanticipated event drove down price. If you can’t quantify the risk, don’t buy it. 8.6% yield. Distribution is safe.

Showing 136 to 150 of 237 entries

Most Recent Experts

Jim Cramer - Mad Money

CNBC

Larry Berman CFA, CMT, CTA

ETF Capital Management Inc.

Mike Vinokur, CFA, CMT, and CFP

Propellus Wealth Partners/iA Private Wealth

Brian Madden

First Avenue Investment Counsel

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Extendicare Inc (EXE.TO)